Literature DB >> 33426495

False-positive 123I-metaiodobenzylguanidine scan in a patient with renal cell carcinoma: A case of chromophobe renal cell carcinoma oncocytic variant with a complicated clinical course.

Takahito Suyama1, Manato Kanesaka1,2, Ayumi Fujimoto1,2, Kotaro Otsuka1, Kyokushin Hou1, Kazuhiro Araki1, Hiroshi Masuda1, Satoko Kojima1, Kazuto Yamazaki3, Yukio Naya1.   

Abstract

INTRODUCTION: 123I-metaiodobenzylguanidine scanning has high sensitivity and specificity for the diagnosis of tumors derived from sympathetic nerves or the adrenal medulla. We report the rare case of a 123I-metaiodobenzylguanidine false-positive renal cell carcinoma. CASE
PRESENTATION: The patient was referred to our hospital with an incidental left renal mass during evaluation for hypertension. An ovarian tumor and prominent ascites were also observed. Serum and urine catecholamine levels were high to suspect a catecholamine-producing tumor of the kidney. 123I-metaiodobenzylguanidine scintigraphy showed increased 123I-metaiodobenzylguanidine intake in the tumor. Laparoscopic radical left nephrectomy was performed. The pathologic diagnosis was an oncocytic variant of chromophobe renal cell carcinoma. No pheochromocytoma features were found.
CONCLUSION: We report the first case of a 123I-metaiodobenzylguanidine false-positive renal cell carcinoma. This case was diagnosed with primary aldosteronism and Meigs' syndrome, which made the clinical course more complicated.
© 2020 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.

Entities:  

Keywords:  123I‐MIBG false‐positive; Meigs’ syndrome; chromophobe RCC; oncocytic variant

Year:  2020        PMID: 33426495      PMCID: PMC7784746          DOI: 10.1002/iju5.12233

Source DB:  PubMed          Journal:  IJU Case Rep        ISSN: 2577-171X


  11 in total

1.  False positive MIBG scan due to accessory spleen.

Authors:  C Granata; C Carlini; M Conte; F Claudiani; R Campus; A Rizzo
Journal:  Med Pediatr Oncol       Date:  2001-08

2.  False positive metaiodobenzylguanidine scan in a patient with a huge adrenocortical carcinoma.

Authors:  T Rainis; S Ben-Haim; G Dickstein
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

3.  123I-Metaiodobenzylguanidine accumulation in a urinoma and cortex of an obstructed kidney after surgical resection of an abdominal neuroblastoma.

Authors:  Efstratios Moralidis; Georgios Arsos; Eugenia Papakonstantinou; Maria Badouraki; Dimitrios Koliouskas; Constantinos Karakatsanis
Journal:  Pediatr Radiol       Date:  2007-10-02

4.  Meigs' Syndrome: A Sheep in Wolf's Clothing.

Authors:  Jenny A Shih; Leslie A Garrett; Alexander R Carbo
Journal:  Am J Med       Date:  2019-05-30       Impact factor: 4.965

5.  Classic pages in obstetrics and gynecology. Joe Vincent Meigs and John W. Cass. Fibroma of the ovary with ascites and hydrothorax. With a report of seven cases.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  1971-12-01       Impact factor: 8.661

6.  False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma.

Authors:  Y Inoue; M Akahane; T Kitazawa; H Ijichi; S Obi; K Yoshikawa; K Ohtomo; M Omata
Journal:  Br J Radiol       Date:  2002-06       Impact factor: 3.039

Review 7.  Update on basic research and clinical experience with metaiodobenzylguanidine.

Authors:  W H Beierwaltes
Journal:  Med Pediatr Oncol       Date:  1987

8.  Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors.

Authors:  Naoto Kuroda; Azusa Tanaka; Tadanori Yamaguchi; Kotaro Kasahara; Keishi Naruse; Yosuke Yamada; Kanako Hatanaka; Nobuo Shinohara; Yoji Nagashima; Shuji Mikami; Mototsugu Oya; Takeru Hamashima; Michal Michal; Ondrej Hes
Journal:  Med Mol Morphol       Date:  2013-01-22       Impact factor: 2.309

9.  False-positive 123I-metaiodobenzylguanidine (MIBG) scan in a patient with angiomyolipoma; positive MIBG scan does not necessarily indicate the presence of pheochromocytoma.

Authors:  Nobuyuki Takasu; Mina Hayashi; Masaki Takara; Takako Iha; Tsuyoshi Kouki; Yuzuru Ohshiro; Yoshihide Ogawa
Journal:  Intern Med       Date:  2007-10-15       Impact factor: 1.271

10.  SDH-deficient renal cell carcinoma - clinical, pathologic and genetic correlates: a case report.

Authors:  Ravi Kumar; Michael Bonert; Asghar Naqvi; Kevin Zbuk; Anil Kapoor
Journal:  BMC Urol       Date:  2018-11-27       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.